LINCOBUL

This brand name is authorized in Nigeria.

Active ingredients

The drug LINCOBUL contains one active pharmaceutical ingredient (API):

1	Lincomycin UNII M6T05Z2B68 - LINCOMYCIN HYDROCHLORIDE
	Lincomycin is an antibiotic produced by fermentation of Streptomyces lincolnensis. Lincomycin inhibits bacterial protein synthesis by binding to the 50S subunit of the bacterial ribosome.
	Read more about Lincomycin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-8104	Capsule	LINCOBUL CAPSULES CAP 500 mg 3x4	24 RNW-PP-270629 LINCOBUL CAPSULES LINCOMYCIN HYDROCHLORIDE 500MG Lincomycin Hydrochloride BP Eqv. to Lincomycin 500mg EXCIPIENTS: Magnesium Stearate, Colloidal Silicon Dioxide, Purified Talc. A4-8104 Drugs Imported Products 34 POM 1 7/6/2022 MEDNORAL PHARMACEUTICAL LIMITED, NO. 12, CHRIS EBIE STREET, OFF AGO PALACE WAY, OKOTA, LAGOS STATE. 33283730 mednoraln@gmail.com JIANGSU RUINIAN QIAN JIN PHARMACEUTICAL CO, LTD, CHUANBU, YIXING ECONMIC DEVELOPMENT ZONE, JIANGSU PROVINCE, CHINA, China	31/10/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01FF02	Lincomycin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01F Macrolides, lincosamides and streptogramins → J01FF Lincosamides
Discover more medicines within J01FF02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-8104